BusinessProQR Provides Enrollment Update on QR-110 Clinical Trial and Highlights Ophthalmology Presentations at ARVOBy Nasdaq OMXApr 23, 2018, 11:00 AM UTC
BusinessProQR Doses First LCA 10 Patient in Clinical Trial of QR-110, ProQR’s Lead Program for Genetic BlindnessBy Nasdaq OMXNov 13, 2017, 12:00 PM UTC
